Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.37
-0.27 (-3.13%)
At close: Aug 28, 2026, 4:00 PM EDT
8.53
+0.16 (1.91%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Kyverna Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Kyverna Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $30.4. The average 1-year stock price forecast is 263.20% higher than the current stock price, while the lowest is $25 (+198.69%) and the highest is $33 (+294.27%).
Price Target: $30.4 (+263.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Kyverna Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $33 | Buy | Maintains | $33 | +294.27% | Aug 14, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $33 | Buy | Reiterates | $33 | +294.27% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +198.69% | Aug 12, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $30 → $29 | Buy | Reiterates | $30 → $29 | +246.48% | May 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
17.88M
EPS This Year
-2.77
from -3.64
EPS Next Year
-3.07
from -2.77
EPS and Forward PE are based on non-GAAP adjusted numbers.